San Diego, CA, United States of America

Venkatataiah Bollu

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Venkatataiah Bollu: Innovator in Parasitic Disease Treatment

Introduction

Venkatataiah Bollu is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceutical sciences. He holds three patents that focus on innovative compounds and compositions aimed at treating parasitic diseases, particularly malaria. His work is crucial in the ongoing battle against diseases caused by parasites.

Latest Patents

Bollu's latest patents include groundbreaking compounds and compositions for the treatment of parasitic diseases. The inventions provide compounds of formula I or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, with specific variables defined in the patent. These compounds are designed to treat, prevent, inhibit, ameliorate, or eradicate the pathology and symptomology of diseases caused by parasites, such as malaria. This innovative approach has the potential to significantly impact public health.

Career Highlights

Throughout his career, Venkatataiah Bollu has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Irm LLC. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments for parasitic infections.

Collaborations

Bollu has collaborated with talented individuals in his field, including Arnab Kumar Chatterjee and Advait Suresh Nagle. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Venkatataiah Bollu is a dedicated inventor whose work in developing treatments for parasitic diseases is making a significant difference in the medical field. His patents and collaborations reflect his commitment to improving health outcomes for those affected by these diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…